ArticleRadiology case reports2025
Veiled in Gynecomastia: A B3 breast lesion in a male patient with subsequent "upgrade" to invasive malignancy.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
B3 breast lesions are a heterogeneous group with uncertain malignant potential. While female-specific guidelines often recommend vacuum-assisted excision (VAE) followed by surveillance, these strategies are less applicable in male patients. This case report highlights a male patient initially diagnosed with a B3 lesion-specifically atypical intraductal epithelial proliferation (AIDEP)-that was later "upgraded" to invasive carcinoma and ductal carcinoma in situ (DCIS) following surgical excision. The case illustrates the limitations of current protocols when applied to men and supports considering surgical excision as a first-line management strategy in high-risk B3 lesions. It also highlights the potential diagnostic value of mammography in high-risk males, particularly when ultrasound findings are inconclusive. Overall, this report emphasizes the need for male-specific, evidence-based guidelines to ensure timely and accurate diagnosis and treatment of B3 breast lesions in men.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.